Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT03955146 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

393

Enrollment

INDUSTRY

Sponsor class

Stopped Study did not meet its primary endpoint.

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Pamrevlumab
DRUG: Placebo

Sponsor

Kyntra Bio